Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66]
Research output: Contribution to specialist publication › Corrections (errata and retractions) › peer-review
Contributors
Details
Original language | English |
---|---|
Pages | 454 |
Volume | 33 |
Issue number | 4 |
Journal | Annals of Oncology |
Publication status | Published - Apr 2022 |
Peer-reviewed | Yes |
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical
External IDs
Scopus | 85123691928 |
---|